CAS: 1221277-90-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK 2033 REF: IN-DA00A1FSCAS: 1221277-90-2 | 98% | To inquire | Mon 25 Nov 24 |
 | GSK2033 REF: TM-T15427CAS: 1221277-90-2 | 99.05% | 52.00 €~1,458.00 € | Mon 02 Dec 24 |
 | GSK 2033 REF: TR-G797833CAS: 1221277-90-2 | - - - | 2,167.00 € | Fri 03 Jan 25 |
 | GSK2033 REF: 3D-WYB27790CAS: 1221277-90-2 | Min. 95% | To inquire | Tue 07 Jan 25 |
GSK 2033
CAS:1221277-90-2
Formula:
C29H28F3NO5S2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
591.6615
Ref: IN-DA00A1FS
| 5mg | 159.00 € | ||
| 10mg | 281.00 € | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 25 Nov 2024
GSK2033
CAS:1221277-90-2
GSK2033 is an antagonist of LXR (pIC50s: 7 and 7.4 for LXRα or LXRβ, respectively).
Formula:
C29H28F3NO5S2
Purity:
99.05%
Color and Shape:
Solid
Molecular weight:
591.66
Ref: TM-T15427
| 1mg | 52.00 € | ||
| 5mg | 94.00 € | ||
| 10mg | 157.00 € | ||
| 25mg | 251.00 € | ||
| 50mg | 403.00 € | ||
| 100mg | 648.00 € | ||
| 500mg | 1,458.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
GSK 2033
Controlled ProductCAS:1221277-90-2
Formula:
C29H28F3NO5S2
Color and Shape:
Neat
Molecular weight:
591.662
Ref: TR-G797833
| 250mg | 2,167.00 € |
Estimated delivery in United States, on Friday 3 Jan 2025
GSK2033
CAS:1221277-90-2
GSK2033 is a novel small molecule that inhibits the ATP-binding cassette transporter A1 (ABCA1) which …
Formula:
C29H28F3NO5S2
Purity:
Min. 95%
Molecular weight:
591.66 g/mol
Ref: 3D-WYB27790
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
